AVVie Overview
- Status
-
Acquired/Merged
- Employees
-
11
- Latest Deal Type
-
M&A
AVVie General Information
Description
Developer of structural heart medical devices designed to treat mitral valve regurgitation and related heart failure conditions. The company offers a hemi valve replacement system that restores posterior leaflet function, enabling cardiac patients to receive minimally invasive treatment for improved heart valve performance and quality of life.
Contact Information
Website
www.angelvalve.com(Operating Subsidiary)
Corporate Office
- Lazarettgasse 12/19
- Vienna, Vienna 1090
- Austria
Corporate Office
- Lazarettgasse 12/19
- Vienna, Vienna 1090
- Austria
AVVie Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 05-Aug-2026 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 21-Jun-2024 | Completed | Generating Revenue | |||
| 7. Grant | 15-Jun-2022 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 06-Jun-2021 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A) | Cancelled | Generating Revenue | ||||
| 4. Grant | 28-Oct-2019 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 01-Jul-2019 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 29-Sep-2017 | $1.19M | $1.19M | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2017 | Completed | Startup |
AVVie Comparisons
Industry
Financing
Details
AVVie Competitors (1)
One of AVVie’s competitors is Abbott, a Corporation company based in Abbot Park, IL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Abbott | Corporation | Abbot Park, IL |
AVVie Patents
AVVie Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4813352-A1 | Method of manufacturing a hemivalve prosthesis | Pending | 24-Mar-2025 | ||
| WO-2026202026-A1 | Method of manufacturing a hemivalve prosthesis | Pending | 24-Mar-2025 | ||
| EP-4649919-A1 | Implant for improving coaptation of an atrioventricular valve in a human heart | Pending | 13-May-2024 | ||
| WO-2025237961-A1 | Implant for improving coaptation of an atrioventricular valve in a human heart | Pending | 13-May-2024 | ||
| EP-4403136-A1 | Implant for improving coaptation of an atrioventricular valve | Inactive | 23-Jan-2023 | A61F2/246 |
AVVie Signals
AVVie Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Austria Wirtschaftsservice | Venture Capital | Minority | ||
| European Innovation Council | Accelerator/Incubator | Minority | ||
| INiTS Universitäres Gründerservice | Accelerator/Incubator | Minority | ||
| Ivascular | Corporation | |||
| Medical University of Vienna | University |
AVVie FAQs
-
Where is AVVie headquartered?
AVVie is headquartered in Vienna, Austria.
-
What is the size of AVVie?
AVVie has 11 total employees.
-
What industry is AVVie in?
AVVie’s primary industry is Surgical Devices.
-
Is AVVie a private or public company?
AVVie is a Private company.
-
What is AVVie’s current revenue?
The current revenue for AVVie is .
-
How much funding has AVVie raised over time?
AVVie has raised $10.1M.
-
Who are AVVie’s investors?
Austria Wirtschaftsservice, European Innovation Council, INiTS Universitäres Gründerservice, Ivascular, and Medical University of Vienna are 5 of 7 investors who have invested in AVVie.
-
Who are AVVie’s competitors?
Abbott is a competitor of AVVie.
-
When was AVVie acquired?
AVVie was acquired on 05-Aug-2026.
-
Who acquired AVVie?
AVVie was acquired by P&F Products & Features.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process